These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30734249)

  • 21. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China.
    Qi Y; Wei Z; Ji S; Du X; Shen P; Yu Y
    J Antimicrob Chemother; 2011 Feb; 66(2):307-12. PubMed ID: 21131324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae.
    Ariza-Heredia EJ; Patel R; Blumberg EA; Walker RC; Lewis R; Evans J; Sankar A; Willliams MD; Rogers J; Milano C; Razonable RR
    Transpl Infect Dis; 2012 Jun; 14(3):229-36. PubMed ID: 22624726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.
    Gatti M; Raschi E; De Ponti F
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):65. PubMed ID: 31718688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae.
    Kulengowski B; Campion JJ; Feola DJ; Burgess DS
    J Antibiot (Tokyo); 2017 Aug; 70(9):974-978. PubMed ID: 28676713
    [No Abstract]   [Full Text] [Related]  

  • 25. Meropenem heteroresistance in clinical isolates of OXA-48-producing Klebsiella pneumoniae.
    López-Camacho E; Paño-Pardo JR; Sotillo A; Elías-López C; Martínez-Martínez L; Gómez-Gil R; Mingorance J
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):162-166. PubMed ID: 30297092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China.
    Liang Y; Yin X; Zeng L; Chen S
    BMC Infect Dis; 2017 May; 17(1):363. PubMed ID: 28535790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
    Crémieux AC; Dinh A; Nordmann P; Mouton W; Tattevin P; Ghout I; Jayol A; Aimer O; Gatin L; Verdier MC; Saleh-Mghir A; Laurent F
    J Antimicrob Chemother; 2019 Sep; 74(9):2666-2675. PubMed ID: 31263884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
    Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
    J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.
    Bergamasco MD; Barroso Barbosa M; de Oliveira Garcia D; Cipullo R; Moreira JC; Baia C; Barbosa V; Abboud CS
    Transpl Infect Dis; 2012 Apr; 14(2):198-205. PubMed ID: 22093103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
    Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China.
    Chen J; Wang D; Ding Y; Zhang L; Li X
    Microb Drug Resist; 2019 Mar; 25(2):251-257. PubMed ID: 30113251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Tigecycline Resistance in Carbapenemase-Producing
    Yoon EJ; Oh Y; Jeong SH
    Ann Lab Med; 2020 Jan; 40(1):15-20. PubMed ID: 31432634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal dissemination of multilocus sequence type 11 Klebsiella pneumoniae carbapenemase - producing K. pneumoniae in a Chinese teaching hospital.
    Sun K; Chen X; Li C; Yu Z; Zhou Q; Yan Y
    APMIS; 2015 Feb; 123(2):123-7. PubMed ID: 25257726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of antimicrobial combinations against KPC-2-producing Klebsiella pneumoniae in a rat model and time-kill assay.
    Toledo PV; Aranha Junior AA; Arend LN; Ribeiro V; Zavascki AP; Tuon FF
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4301-4. PubMed ID: 25896686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniae.
    DeSarno AE; Parcell BJ; Coote PJ
    Pathog Dis; 2020 Dec; 78(9):. PubMed ID: 33053176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
    J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
    Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
    Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergy Testing by E-Test and Microdilution Checkerboard for Fosfomycin Combined with Tigecycline against KPC-Producing Klebsiella pneumoniae.
    Huang L; Wang M; Sun L
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.